Peter Beitsch MD

HIP - is an opportunistic venture capital firm that uses a unique multi-disciplinary collaborative ecosystem model to fund innovation in healthcare. A firm with a TRUE NORTH of conducting the most detailed and complete early stage diligence in the industry - HIP has grown to over 275 investors (including 90 institutional including 18 health system strategic investors). HIP endorses an opportunity for investment ONLY after its extensive diligence and deploys capital through its Fund and sidecar - deal by deal investment vehicle. In parallel - institutional investors in HIP deploy capital through their own structures and funds based on their independent decision but heavily weighed by the collective HIP endorsement and powerful HIP model/process. As of late 2024 - HIP portfolio has 12 early stage healthcare technology companies. With over 75% having received multiple rounds of funding from the HIP ecosystem. Visit our site for details to join our mission as an investor in healthcare or to seek audience for investment (fill out a short sign up form)

HIP - is an opportunistic venture capital firm that uses a unique multi-disciplinary collaborative ecosystem model to fund innovation in healthcare. A firm with a TRUE NORTH of conducting the most detailed and complete early stage diligence in the industry - HIP has grown to over 275 investors (including 90 institutional including 18 health system strategic investors). HIP endorses an opportunity for investment ONLY after its extensive diligence and deploys capital through its Fund and sidecar - deal by deal investment vehicle. In parallel - institutional investors in HIP deploy capital through their own structures and funds based on their independent decision but heavily weighed by the collective HIP endorsement and powerful HIP model/process. As of late 2024 - HIP portfolio has 12 early stage healthcare technology companies. With over 75% having received multiple rounds of funding from the HIP ecosystem. Visit our site for details to join our mission as an investor in healthcare or to seek audience for investment (fill out a short sign up form)

The TME Breast Care Network is an Aptitude Health copmany and a group of community-leading breast cancer doctors whose goal is to cut through the avalanche of "new developments"​ in breast cancer, eliminating the spurious, and implementing genuine advances. In addition we are preparing for big changes ahead including the expansion of multi-gene panel testing and precision medicine driven by genomic and molecular testing. We believe most doctors make changes in practice with difficulty and usually only after extensive discussions with trusted colleagues. Our fall Key Opinion Leaders Roundtable Summit intentionally hosts direct peer exchange among community leaders so we all make progress together, with the confidence that setting can build. www.BreastCareNetwork.com is continually updated to reflect these advances. We are growing the Breast Care Network to replicate and promulgate this format as an efficient way for leading breast care doctors (including ourselves) to keep up with meaningful developments, avoid blind alleys, and bring genuine progress to their communities. We believe this approach is enjoyable for the participating KOLs. Moreover this KOL-targeted approach provides a very efficient way for innovative researchers and medical companies to work with leaders in the medical community. Medical progress happens most efficiently when doctors and industry innovators communicate openly, eliminate conflicts and develop better solutions.

Our specialty is dealing with cancer and surgical oncology. Our chief physician is Dr. Peter Beitsch, who is widely recognized for excellence in surgical oncology, breast cancer surgery and the care of the patient with all stages of melanoma. Our mission is to provide you with the most accurate, innovative, and technologically advanced surgical management of cancer care in Dallas, Texas. If you are in the Southwest or anywhere in the US and need advanced treatment modalities we encourage you to contact us